Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study
Sanne Menning, Michiel B. de Ruiter, Dick J. Veltman, et al.
Brain Imaging and Behavior (2017) Vol. 12, Iss. 2, pp. 324-334
Closed Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors
Marie Lange, Florence Joly, Janette Vardy, et al.
Annals of Oncology (2019) Vol. 30, Iss. 12, pp. 1925-1940
Open Access | Times Cited: 486
Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study
Jeanne S. Mandelblatt, Brent J. Small, George Luta, et al.
Journal of Clinical Oncology (2018) Vol. 36, Iss. 32, pp. 3211-3222
Open Access | Times Cited: 153
Microglia in Cancer Therapy-Related Cognitive Impairment
Erin M. Gibson, Michelle Monje
Trends in Neurosciences (2021) Vol. 44, Iss. 6, pp. 441-451
Open Access | Times Cited: 75
Adaptive and maladaptive myelination in health and disease
Juliet K. Knowles, Ankita Batra, Haojun Xu, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 12, pp. 735-746
Closed Access | Times Cited: 42
Neuron–oligodendroglial interactions in health and malignant disease
Kathryn R. Taylor, Michelle Monje
Nature reviews. Neuroscience (2023) Vol. 24, Iss. 12, pp. 733-746
Open Access | Times Cited: 30
Doxorubicin chemotherapy-induced “chemo-brain”: Meta-analysis
Sarah Eide, Zhong‐Ping Feng
European Journal of Pharmacology (2020) Vol. 881, pp. 173078-173078
Closed Access | Times Cited: 68
Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer
Gwen Schroyen, Jeroen Blommaert, Donatienne Van Weehaeghe, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4198-4198
Open Access | Times Cited: 42
Emerging mechanistic underpinnings and therapeutic targets for chemotherapy-related cognitive impairment
Erin M. Gibson, Michelle Monje
Current Opinion in Oncology (2019) Vol. 31, Iss. 6, pp. 531-539
Open Access | Times Cited: 46
The Developmental Trajectory of Cancer-Related Cognitive Impairment in Breast Cancer Patients: A Systematic Review of Longitudinal Neuroimaging Studies
Helena Sousa, Susana Almeida, João M. Bessa, et al.
Neuropsychology Review (2020) Vol. 30, Iss. 3, pp. 287-309
Open Access | Times Cited: 46
Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions
Giovana R. Onzi, Nathalia D’Agustini, Solange Cristina García, et al.
Drug Safety (2022) Vol. 45, Iss. 6, pp. 601-621
Closed Access | Times Cited: 23
Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study
Bihong T. Chen, Sean K. Sethi, Taihao Jin, et al.
Breast Cancer Research (2018) Vol. 20, Iss. 1
Open Access | Times Cited: 38
Systematic review of longitudinal studies on chemotherapy‐associated subjective cognitive impairment in cancer patients
Hee‐Ju Kim, Sun Ok Jung, Hyang Kim, et al.
Psycho-Oncology (2020) Vol. 29, Iss. 4, pp. 617-631
Closed Access | Times Cited: 38
Chemotherapy-related cognitive impairment in patients with breast cancer based on MRS and DTI analysis
Taishan Tong, Heng Lu, Jian Zong, et al.
Breast Cancer (2020) Vol. 27, Iss. 5, pp. 893-902
Closed Access | Times Cited: 33
Chemotherapy-induced cognitive impairments: White matter pathologies
A. Matsos, Max Loomes, Iris Y. Zhou, et al.
Cancer Treatment Reviews (2017) Vol. 61, pp. 6-14
Closed Access | Times Cited: 34
Age‐dependent brain volume and neuropsychological changes after chemotherapy in breast cancer patients
Jeroen Blommaert, Gwen Schroyen, Mathieu Vandenbulcke, et al.
Human Brain Mapping (2019) Vol. 40, Iss. 17, pp. 4994-5010
Open Access | Times Cited: 32
Structural Neuroimaging Findings Related to Adult Non-CNS Cancer and Treatment: Review, Integration, and Implications for Treatment of Cognitive Dysfunction
Brenna C. McDonald
Neurotherapeutics (2021) Vol. 18, Iss. 2, pp. 792-810
Open Access | Times Cited: 26
Effect of physical exercise on cognitive function and brain measures after chemotherapy in patients with breast cancer (PAM study): protocol of a randomised controlled trial
Lenja Witlox, Sanne B. Schagen, Michiel B. de Ruiter, et al.
BMJ Open (2019) Vol. 9, Iss. 6, pp. e028117-e028117
Open Access | Times Cited: 28
Structural brain alterations following adult non-CNS cancers: a systematic review of the neuroimaging literature
Ali Amidi, Lisa M. Wu
Acta Oncologica (2019) Vol. 58, Iss. 5, pp. 522-536
Open Access | Times Cited: 26
Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events
Ana Dias-Carvalho, Mariana Ferreira, Rita Ferreira, et al.
Archives of Toxicology (2021) Vol. 96, Iss. 1, pp. 11-78
Closed Access | Times Cited: 21
Effects of chemotherapy on aging white matter microstructure: A longitudinal diffusion tensor imaging study
Bihong T. Chen, Ningrong Ye, Chi Wah Wong, et al.
Journal of Geriatric Oncology (2019) Vol. 11, Iss. 2, pp. 290-296
Open Access | Times Cited: 25
Measuring decline in white matter integrity after systemic treatment for breast cancer: omitting skeletonization enhances sensitivity
Yasmin Mzayek, Michiel B. de Ruiter, Hester S. A. Oldenburg, et al.
Brain Imaging and Behavior (2020) Vol. 15, Iss. 3, pp. 1191-1200
Open Access | Times Cited: 23
Brain white matter microstructural changes in chemotherapy‐treated older long‐term breast cancer survivors
E Furst Daniel, Frank Deng, Sunita K. Patel, et al.
Cancer Medicine (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Managing menopausal symptoms after breast cancer – A multidisciplinary approach
Paul A. Cohen, Annabelle Brennan, Jennifer L. Marino, et al.
Maturitas (2017) Vol. 105, pp. 4-7
Open Access | Times Cited: 22
Complex challenges for patients with protracted incurable cancer: an ethnographic study in a comprehensive cancer centre in the Netherlands
Hilde M. Buiting, Marleen A C van Ark, Otto Dethmers, et al.
BMJ Open (2019) Vol. 9, Iss. 3, pp. e024450-e024450
Open Access | Times Cited: 20
Clemastine Rescues Chemotherapy-Induced Cognitive Impairment by Improving White Matter Integrity
Yingxi Chen, Jie Sheng, Xiuying Tang, et al.
Neuroscience (2022) Vol. 484, pp. 66-79
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top